NCT05500391 2026-03-18
SUR-CAN
Centre Oscar Lambret
Phase 2 Recruiting
Clinical Trials
12 trialsNCT06309745 2026-03-02
THERATEST
Queen Mary University of London
Recruiting
NCT07218913 2026-01-26
Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors
City of Hope Medical Center
Phase 1 Recruiting
NCT05345158 2025-12-19
R-RPLND as First-line Treatment for Clinical Stage IIA/B Testicular Seminoma
University Health Network, Toronto
Phase NA Recruiting
NCT06133543 2025-09-15
RAISN
Heinrich-Heine University, Duesseldorf
Phase NA Recruiting
NCT06144736 2025-09-15
PRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLND
Heinrich-Heine University, Duesseldorf
Phase 2 Recruiting
NCT06418789 2025-08-03
GERMAN
N.N. Petrov National Medical Research Center of Oncology
Phase 2 Recruiting
NCT06932458 2025-07-20
RPLND-Seminoma
Western University, Canada
Phase 2 Recruiting
NCT05142982 2025-02-11
Radiotherapy vs Observation for Post Chemotherapy Residual Mass in Advanced Seminoma
Tata Memorial Centre
Phase NA Recruiting
NCT05529251 2024-01-25
EDEN
Centre Leon Berard
Phase 2 Recruiting
NCT04914026 2022-08-08
MicroRNA as Markers in Testicular Cancer
Haukeland University Hospital
Recruiting
NCT01887340 2016-06-09
SEMITEP
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2 Recruiting